Arcadia, CA, United States of America

Ravinder Abrol

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 11(Granted Patents)


Location History:

  • Arcadia, CA (US) (2014 - 2019)
  • Pasadena, CA (US) (2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Ravinder Abrol

Introduction

Ravinder Abrol is a notable inventor based in Arcadia, California. He has made significant contributions to the field of science and technology, particularly in the areas of hormone modulation and protein structure prediction. With a total of four patents to his name, Abrol's work has the potential to impact various medical and pharmaceutical applications.

Latest Patents

Abrol's latest patents include innovative methods and systems for modulating hormones. These patents provide bitter taste receptor ligands and related agents, which are designed to modulate the release of metabolic hormones from gastrointestinal cells. Another significant patent focuses on predicting the three-dimensional structures of alpha-helical membrane proteins. This method allows for the practical prediction of binding sites and structures for ligands, which is crucial for drug design and efficacy.

Career Highlights

Throughout his career, Ravinder Abrol has worked with prestigious institutions such as the California Institute of Technology and the University of California. His research has contributed to advancements in understanding protein interactions and hormone regulation, showcasing his expertise in the field.

Collaborations

Abrol has collaborated with notable individuals in his field, including William A. Goddard III and Mark Menna. These collaborations have further enriched his research and innovations.

Conclusion

Ravinder Abrol's contributions to science and technology through his patents and research collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical and pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…